- In June 2019, General Electric and Daiichi Sankyo Company signed an agreement that Daiichi Sankyo to transfer the authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After completing this agreement, the company expanded its diagnostic imaging agents in Japan. This will help company to grow its business in the market.
Frequently Asked Questions
The market is segmented based on North America Iodinated Contrast Media in Interventional X-Ray Market Segmentation, By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2032
.
The North America Iodinated Contrast Media In Interventional X Ray Market size was valued at USD 1.24 USD Billion in 2024.
The North America Iodinated Contrast Media In Interventional X Ray Market is projected to grow at a CAGR of 5.8% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada, Mexico.
